Intrinsic pro-angiogenic status of cystic fibrosis airway epithelial cells

Biochemical and Biophysical Research Communications

Volumn 356, Issue 3, 2007, Pages 745-749

  Verhaeghe, Catherine ^a   Tabruyn, Sebastien P ^b   Oury, Cecile ^a   Bours, Vincent ^a   Griffioen, Arjan W ^b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b GROW   (Netherlands)

Author keywords

Angiogenesis; Cystic fibrosis; Endothelial cells; Epithelial cells; Lung Inflammation; VEGF

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; THROMBOSPONDIN 1; VASCULOTROPIN A; VASCULOTROPIN C;

ANGIOGENESIS; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; CYSTIC FIBROSIS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROSIS; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM;

CELL LINE; CELL MOVEMENT; CYSTIC FIBROSIS; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; RESPIRATORY SYSTEM; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33947697717     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.02.166     Document Type: Article

References (26)

1. Koehler D.R., Downey G.P., Sweezey N.B., Tanswell A.K., and Hu J. Lung inflammation as a therapeutic target in cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 31 (2004) 377-381
2. Wilson J.W., and Robertson C.F. Angiogenesis in paediatric airway disease. Paediatr. Respir. Rev. 3 (2002) 219-229
3. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 438 (2005) 932-936
4. Keane M.P., Strieter R.M., Lynch III J.P., and Belperio J.A. Inflammation and angiogenesis in fibrotic lung disease. Semin. Respir. Crit. Care Med. 27 (2006) 589-599
5. Flume P.A., Yankaskas J.R., Ebeling M., Hulsey T., and Clark L.L. Massive hemoptysis in cystic fibrosis. Chest 128 (2005) 729-738
6. McColley S.A., Stellmach V., Boas S.R., Jain M., and Crawford S.E. Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation. Am. J. Respir. Crit. Care Med. 161 (2000) 1877-1880
7. Lemnaouar M., Chastre E., Paul A., Mergey M., Veissiere D., Cherqui G., Barbry P., Simon-Bouy B., Fanen P., Gespach C., et al. Oncogene-mediated propagation of tracheal epithelial cells from two cystic fibrosis fetuses with different mutations. Characterization of CFT-1 and CFT-2 cells in culture. Eur. J. Clin. Invest. 23 (1993) 151-160
8. Medjane S., Raymond B., Wu Y., and Touqui L. Impact of CFTR DeltaF508 mutation on prostaglandin E2 production and type IIA phospholipase A2 expression by pulmonary epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 289 (2005) L816-L824
9. Dirkx A.E., oude Egbrink M.G., Castermans K., van der Schaft D.W., Thijssen V.L., Dings R.P., Kwee L., Mayo K.H., Wagstaff J., Bouma-ter Steege J.C., and Griffioen A.W. Anti-angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte-endothelium interactions and infiltration in tumors. FASEB J. 20 (2006) 621-630
10. Olivier S., Close P., Castermans E., de Leval L., Tabruyn S., Chariot A., Malaise M., Merville M.P., Bours V., and Franchimont N. Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-kappaB inhibition and gene expression signature. Mol. Pharmacol. 69 (2006) 1615-1623
11. Brandwijk R.J., Dings R.P., van der Linden E., Mayo K.H., Thijssen V.L., and Griffioen A.W. Anti-angiogenesis and anti-tumor activity of recombinant anginex. Biochem. Biophys. Res. Commun. 349 (2006) 1073-1078
12. Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology 69 Suppl. 3 (2005) 4-10
13. McDonald D.M. Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am. J. Respir. Crit. Care Med. 164 (2001) S39-S45
14. Rowe S.M., Miller S., and Sorscher E.J. Cystic fibrosis. N. Engl. J. Med. 352 (2005) 1992-2001
15. Dakin C.J., Numa A.H., Wang H., Morton J.R., Vertzyas C.C., and Henry R.L. Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 165 (2002) 904-910
16. Verhaeghe C., Delbecque K., de Leval L., Oury C., and Bours V. Early inflammation in the airways of a cystic fibrosis foetus. J. Cyst. Fibros. (2007)
17. Hubeau C., Puchelle E., and Gaillard D. Distinct pattern of immune cell population in the lung of human fetuses with cystic fibrosis. J. Allergy Clin. Immunol. 108 (2001) 524-529
18. Rosenfeld M., Gibson R.L., McNamara S., Emerson J., Burns J.L., Castile R., Hiatt P., McCoy K., Wilson C.B., Inglis A., Smith A., Martin T.R., and Ramsey B.W. Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr. Pulmonol. 32 (2001) 356-366
19. Balough K., McCubbin M., Weinberger M., Smits W., Ahrens R., and Fick R. The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatr. Pulmonol. 20 (1995) 63-70
20. Baffert F., Le T., Thurston G., and McDonald D.M. Angiopoietin-1 decreases plasma leakage by reducing number and size of endothelial gaps in venules. Am. J. Physiol. Heart Circ. Physiol. 290 (2006) H107-H118
21. Kim K.E., Cho C.H., Kim H.Z., Baluk P., McDonald D.M., and Koh G.Y. In vivo actions of angiopoietins on quiescent and remodeling blood and lymphatic vessels in mouse airways and skin. Arterioscler. Thromb. Vasc. Biol. (2006)
22. Knorre A., Wagner M., Schaefer H.E., Colledge W.H., and Pahl H.L. DeltaF508-CFTR causes constitutive NF-kappaB activation through an ER-overload response in cystic fibrosis lungs. Biol. Chem. 383 (2002) 271-282
23. Cigana C., Nicolis E., Pasetto M., Assael B.M., and Melotti P. Anti-inflammatory effects of azithromycin in cystic fibrosis airway epithelial cells. Biochem. Biophys. Res. Commun. 350 (2006) 977-982
24. Tabary O., Escotte S., Couetil J.P., Hubert D., Dusser D., Puchelle E., and Jacquot J. Relationship between IkappaBalpha deficiency, NFkappaB activity and interleukin-8 production in CF human airway epithelial cells. Pflugers Arch. 443 Suppl. 1 (2001) S40-S44
25. DiMango E., Ratner A.J., Bryan R., Tabibi S., and Prince A. Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. J. Clin. Invest. 101 (1998) 2598-2605
26. Venkatakrishnan A., Stecenko A.A., King G., Blackwell T.R., Brigham K.L., Christman J.W., and Blackwell T.S. Exaggerated activation of nuclear factor-kappaB and altered IkappaB-beta processing in cystic fibrosis bronchial epithelial cells. Am. J. Respir. Cell. Mol. Biol. 23 (2000) 396-403